Safety, Reactogenicity and Immunogenicity Study of ReCOV
Clinical trial NCT04818801 · COMPLETED
Trial details
- NCT number
- NCT04818801
- Sponsor
- Jiangsu Rec-Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-18
- Primary completion
- 2022-05-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.